Vivani Medical, Inc. (NASDAQ:VANI) Director Gregg Williams Purchases 3,968,253 Shares

Vivani Medical, Inc. (NASDAQ:VANI) Director Gregg Williams purchased 3,968,253 shares of the business’s stock in a transaction dated Friday, November 8th. The shares were bought at an average price of $1.26 per share, with a total value of $4,999,998.78. Following the purchase, the director now directly owns 4,695,861 shares of the company’s stock, valued at approximately $5,916,784.86. The trade was a 500.00 % increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink.

Vivani Medical Price Performance

NASDAQ VANI opened at $1.25 on Wednesday. Vivani Medical, Inc. has a 52-week low of $0.84 and a 52-week high of $7.80. The firm has a 50-day moving average price of $1.22 and a 200 day moving average price of $1.36.

Vivani Medical (NASDAQ:VANI) last issued its earnings results on Tuesday, August 13th. The company reported ($0.10) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.12) by $0.02.

Wall Street Analyst Weigh In

Separately, HC Wainwright began coverage on shares of Vivani Medical in a research note on Thursday, November 7th. They issued a “buy” rating and a $3.00 price objective on the stock.

About Vivani Medical

Vivani Medical, Inc, a clinical stage company, develops various implants that treat chronic diseases with high unmet medical need. It engages in developing a portfolio of miniature drug implants to deliver minimally fluctuating drug profiles; and implantable visual prostheses devices to deliver useful artificial vision to blind individuals.